8-KLeadership Changes

BOSTON SCIENTIFIC CORP 8-K Report, Executive Changes (Oct 23, 2025)

Filed October 23, 2025For Securities:BSX

Summary

Boston Scientific Corporation (BSX) has announced that John E. Sununu will not seek re-election to the Board of Directors at the 2026 Annual Meeting of Stockholders. Mr. Sununu has been a director since April 2009 and currently holds significant roles as a member of the Audit Committee and the chair of the Nominating and Governance Committee. His departure, effective after the 2026 Annual Meeting, is stated to be voluntary and not due to any disagreements with the company. This change marks the end of a long tenure for a director who has contributed to key board functions.

Key Highlights

  • 1John E. Sununu will not stand for re-election at the 2026 Annual Meeting.
  • 2Mr. Sununu has served on the Board of Directors since April 2009.
  • 3He currently chairs the Nominating and Governance Committee.
  • 4Mr. Sununu is also a member of the Audit Committee.
  • 5His decision is not due to any disagreement with the Company.
  • 6Mr. Sununu will continue his board and committee duties until the 2026 Annual Meeting.
  • 7The Board will evaluate potential additions to its composition following his departure.

Frequently Asked Questions

John E. Sununu is a member of Boston Scientific's Board of Directors, serving since April 2009. He currently chairs the Nominating and Governance Committee and is a member of the Audit Committee.

Mr. Sununu has informed the company that he will not stand for re-election at the 2026 Annual Meeting. The filing explicitly states that this decision is not the result of any disagreement with the Company.

Mr. Sununu will continue to serve as a director and in his committee roles until the 2026 Annual Meeting of Stockholders. His departure will be effective after that meeting.

The Board and Nominating and Governance Committee will regularly review the size and composition of the Board and will evaluate whether adding directors following Mr. Sununu's departure is in the best interest of the Company.